NLS

Understanding the science is one thing, but being able to manufacture T-cell therapies at scale is a different matter. TCR-T cell therapies offer a path forward at a fraction of the cost and time of manufacturing a living cell as a product. 

More than three decades after their discovery of microRNA, Professor Gary Ruvkun received the “mythic call” from Stockholm to learn that he’d been awarded the Nobel Prize in Physiology or Medicine alongside his erstwhile colleague Victor Ambros.

BIO-Europe 2024 was held at Stockholmsmässan in Älvsjö on November 4-6, and Nordic Life Science asked three Norwegian life science profiles about their impressions and reasons for attending.

Biotech talent in production is in high demand and Anocca is taking a creative approach to workforce development: investing in motivated young people through in-house training and education.

In a financial market that’s still catching its breath after the repeated turmoil of the past few years, many up-and-coming life science companies in the Nordics are struggling to secure investments and bring their product to market.

Sweden boasts a global reputation for cutting-edge research and innovation, but the country's ambition to maintain its leading position as an innovation nation faces a significant challenge: securing and retaining top talent from abroad. Why then is the route to work permits for international professionals complex and lengthy?